Federated Hermes’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-11,828
| Closed | -$17.3K | – | 2061 |
|
|
2025
Q1 | $17.3K | Sell |
11,828
-11,543
| -49% | -$16.9K | ﹤0.01% | 1746 |
|
|
2024
Q4 | $49.8K | Buy |
23,371
+3,640
| +18% | +$7.75K | ﹤0.01% | 1665 |
|
|
2024
Q3 | $55.2K | Buy |
19,731
+7,431
| +60% | +$20.8K | ﹤0.01% | 1639 |
|
|
2024
Q2 | $28.7K | Buy |
+12,300
| New | +$28.7K | ﹤0.01% | 1683 |
|
|
2023
Q3 | – | Sell |
-170
| Closed | -$845 | – | 2092 |
|
|
2023
Q2 | $845 | Hold |
170
| – | – | ﹤0.01% | 2031 |
|
|
2023
Q1 | $840 | Sell |
170
-273,683
| -100% | -$1.35M | ﹤0.01% | 2052 |
|
|
2022
Q4 | $1.72M | Buy |
273,853
+273,810
| +636,767% | +$1.72M | ﹤0.01% | 958 |
|
|
2022
Q3 | $1K | Hold |
43
| – | – | ﹤0.01% | 2003 |
|
|
2022
Q2 | $1K | Sell |
43
-58,650
| -100% | -$1.36M | ﹤0.01% | 2019 |
|
|
2022
Q1 | $535K | Buy |
+58,693
| New | +$535K | ﹤0.01% | 1436 |
|
|
2021
Q1 | – | Sell |
-16,044
| Closed | -$405K | – | 2214 |
|
|
2020
Q4 | $405K | Sell |
16,044
-68,044
| -81% | -$1.72M | ﹤0.01% | 1566 |
|
|
2020
Q3 | $3.17M | Sell |
84,088
-33,619
| -29% | -$1.27M | 0.01% | 848 |
|
|
2020
Q2 | $5.04M | Buy |
+117,707
| New | +$5.04M | 0.01% | 710 |
|
|
2019
Q2 | – | Sell |
-175,000
| Closed | -$5.06M | – | 2158 |
|
|
2019
Q1 | $5.06M | Hold |
175,000
| – | – | 0.01% | 786 |
|
|
2018
Q4 | $4.71M | Buy |
+175,000
| New | +$4.71M | 0.01% | 746 |
|